SGP
SpyGlass Pharma, Inc.
NASDAQ: SGP · HEALTHCARE · BIOTECHNOLOGY
$22.94
+3.66% today
Updated 2026-04-30
Market cap
$786.19M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.25
Dividend yield
—
52W range
$20 – $32
Volume
0.1M
WallStSmart proprietary scores
23
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$45.00
+96.16%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-9.75M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-13.32M | $-29.16M | $-39.87M | $-12.56M |
| EPS | — | — | — | $-1.25 |
| Free cash flow | $-12.49M | $-24.02M | $-33.49M | $-9.75M |
| Profit margin | — | — | — | — |
Peer comparison
Smart narrative
SpyGlass Pharma, Inc. trades at $22.94. Our Smart Value Score of 23/100 indicates the stock is weak.
Frequently asked questions
What is SpyGlass Pharma, Inc.'s stock price?
SpyGlass Pharma, Inc. (SGP) trades at $22.94.
Is SpyGlass Pharma, Inc. overvalued?
Smart Value Score 23/100 (Grade F, Strong Sell).
What is the price target of SpyGlass Pharma, Inc. (SGP)?
The analyst target price is $45.00, representing +96.2% upside from the current price of $22.94.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-67.70%
Beta—
50D MA$25.72
200D MA$25.81
Shares out0.03B
Float0.01B
Short ratio—
Avg volume0.1M
Performance
1 week-2.67%
1 month-11.23%
3 months—
YTD—
1 year—
3 years—
5 years—